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Editors: Anton N. Sidawy and Bruce A. PerlerInterfacility transfer and mortality for patients with
ruptured abdominal aortic aneurysm
Matthew W., Mell, Nancy E., Wang, Doug E., Morrison,
Tina, Hernandez-Boussard
Objective: Patients receiving interfacility transfer to a
higher level of medical care for ruptured abdominal aortic
aneurysms (rAAAs) are an important minority that are not
well characterized and are typically omitted from outcomes
and quality indicator studies. Our objective was to compare
patients transferred for treatment of rAAAs with those
treated without transfer, with particular emphasis on mor-
tality and resource utilization.
Methods: We linked longitudinal data from 2005 to 2010
Healthcare Cost and Utilization Project (HCUP) State Inpa-
tient Databases and Emergency Department Databases
from California, Florida, and New York. Patients were
identiﬁed using International Classiﬁcation of Diseases-
Ninth Revision-Clinical Modiﬁcation codes. Our main out-
come variables were mortality, length of stay, and cost. Data
included discharge information on the transfer-out and
transfer-in hospital. We used univariate and multivariate
analysis to identify variables independently associated with
transfer and in-hospital mortality.
Results:Of 4439 rAAA patients identiﬁed with intent to treat,
847 (19.1%) were transferred before receiving operative
repair. Of those transferred, 141 (17%) died without under-
going AAA repair. By multivariate analysis, increasing age in
years (odds ratio [OR] 0.98; 95% conﬁdence interval [CI],
0.97-0.99; P<.001), private insurance vsMedicare (OR, 0.62;
95% CI, 0.47-0.80; P< .001), and increasing comorbidities as
measured by the Elixhauser Comorbidity Index (OR, 0.90;
95% CI, 0.86-0.95; P < .001) were negatively associated with
transfer.Weekend presentation (OR, 1.23; 95% CI, 1.02-1.47;
P = .03) was positively associated with transfer. Transfer was
associated with a lower operative mortality (adjusted OR,
0.81; 95% CI, 0.68-0.97; P < .02) but an increased overall
mortality when including transferred patients who died
without surgery (OR, 1.30; 95% CI, 1.05-1.60; P = .01). Among
the transferred patients, there was no signiﬁcant difference
in travel distance between those who survived and those
who died (median, 28.7 vs 25.8 miles; P = .07). Length of stay
(median, 10 vs 9 days; P = .008), and hospital costs ($161,000
vs $146,000; P = .02) were higher for those transferred.
Conclusions: The survival advantage for patients transferred
who received treatment was eclipsed by increased mortality*Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/S1078-5884(14)00439-0of the transfer process. Including 17% of transferred
patients who died without receiving deﬁnitive repair, mor-
tality was increased for patients transferred for rAAA repair
compared with those not transferred after adjusting for
demographic, clinical, and hospital factors. Transferred
patients used signiﬁcantly more hospital resources.
Improving systems and guidelines for interfacility transfer
may further improve the outcomes for these patients and
decrease associated hospital resource utilization.Renal function changes after snorkel/chimney repair of
juxtarenal aneurysms
Jason T., Lee, Vinit N., Varu, Kenneth, Tran, Ronald L.,
Dalman
Objective: The snorkel approach for endovascular aneurysm
repair (EVAR) has been found to be a safe and viable alter-
native to open repair for juxtarenal abdominal aortic
aneurysms with good short-term outcomes. Concerns about
long-term durability and renal branch patency with this
technique have been raised with the increasing availability of
fenestrated devices. We sought to evaluate renal function
changes in patients undergoing “snorkel” EVAR (sn-EVAR).
Methods: Patients who underwent sn-EVAR from 2009 to
2012 were included in this analysis. Creatinine values were
obtained throughout the patient's preoperative, perioper-
ative, and postoperative course. Glomerular ﬁltration rate
(GFR) was estimated by the simpliﬁed Modiﬁcation of Diet
in Renal Disease formula. Acute renal dysfunction was
analyzed according to the RIFLE (Risk, Injury, Failure, Loss,
End stage) criteria, whereas chronic renal dysfunction was
stratiﬁed by the chronic kidney disease staging system.
Results: Forty-three consecutive patients underwent sn-
EVAR (31 double renal, 12 single renal) for juxtarenal aortic
aneurysms. Mean follow-up time was 21 months. Mean
aneurysm size was 6.6 cm (range, 5.1-10.5 cm) with anat-
omy not suitable for treatment with standard EVAR (mean
neck length, 1.6 mm); 74 renal snorkel stents were placed in
these patients with a 2-year primary patency of 95%. On
average, the cohort at baseline was stratiﬁed as having
moderate renal dysfunction. Mean baseline, maximum
postoperative, and latest follow-up creatinine concen-
trations were 1.20, 1.49, and 1.43, respectively (P = .004).
Mean baseline, maximum postoperative, and latest follow-
up GFRs were 57.4, 47.8, and 49.2, respectively (P = .014).
With use of RIFLE criteria, 14 patients (32.6%) experienced
some form of acute kidney injury, although 10 of these
patients (23.3%) were classiﬁed as mild (25%-50% decline in
352 AbstractsGFR). On analysis without the RIFLE criteria, 21.4% of
patients had postoperative creatinine concentration
>1.5 mg/dL, 28.6% had postoperative creatinine concen-
tration increase >30%, and 28.6% had postoperative GFR
decline >30%. For the entire study cohort at latest follow-
up, 51% experienced no decline of chronic renal dysfunction
and 8.1% had improvement in renal function. Renal func-
tion declined by one stage in 35.2% of the cohort and by
two stages in 5.4%. On analysis without chronic kidney
disease staging, 24.3% of patients had latest follow-up
creatinine concentration >1.5 mg/dL, 29.7% had latest fol-
low-up creatinine concentration increase >30%, and 24.3%
had latest follow-up GFR decline >30%. Mean survival time
from signiﬁcant renal decline was 23.4 months.
Conclusions: sn-EVAR continues to demonstrate a high rate
of technical success and results in only mild rates of acute
and midterm renal function decline according to a number
of established deﬁnitions for renal dysfunction. Continued
monitoring of renal function, renal stent behavior, and
abdominal aortic aneurysm sac changes remains critically
important in the long-term management of patients
undergoing sn-EVAR, particularly given the high comorbid-
ities associated with juxtarenal aortic aneurysms.“Off-the-shelf” devices for complex aortic aneurysm repair
Mark A., Farber, Raghuveer, Vallabhaneni, William A.,
Marston
Background: Fenestrated devices currently require a 3- to 4-
week manufacturing period before implantation; as such,
there have been efforts to develop “off-the-shelf” (OTS)
devices to reduce the time before deﬁnitive treatment can be
accomplished. We examined all patients treated for complex
aortic problems at our institution during the past 12months to
evaluate the suitability and early outcomes of the OTS devices
vs commercially available endovascular options.
Methods: Between July 2012 and September 2013, patients
undergoing aortic aneurysm repair were extracted from a
prospectively managed aortic database. Two OTS devices,
the Cook (Bloomington, Ind) p-Branch and the Endologix
(Irvine, Calif) Ventana device, were being evaluated through
clinical trials during this time frame. The custom Cook
Zenith fenestrated endovascular (ZFEN) device was also
available and approved by the U.S. Food and Drug Admin-
istration (FDA) during the study period.
Results: Of 224 aortic aneurysms treated at our institution
during this period, there were a total of 85 patients with type
IV thoracoabdominal aneurysms including juxtarenal aneur-
ysms. Only 23 patients (27%) met anatomic criteria for OTS
devices, with 16 patients having these investigational devices
implanted. The major exclusion criterion for the p-Branch
device was renal axial or circumferential position; the limiting
factor for Ventana was infrasuperior mesenteric artery neck
length restriction. Five of the patients who would have ﬁt
criteria for an OTS device had an FDA-approved (ZFEN) device
implanted instead, and two patients opted for open repair as
a result of follow-up requirements. An additional 25 patientsreceived custom-designed (ZFEN) devices (n = 30; 35%),
whereas 37 (44%) others did not meet criteria for any
available endovascular device and were repaired with alter-
native management strategies. The mean age and maximal
aortic diameter of the two cohorts (OTS and ZFEN) were
71.8 years and 72.7 years (P = NS) and 61.3 mm and 58.5 mm
(P = NS), respectively. Technical success was 100%, with an
overall 30-day mortality of 2.1% (n = 1, ZFEN). Major com-
plications occurred in eight patients (17%; two OTS, six
ZFEN).
Conclusions: Whereas OTS device strategies will reduce
the waiting times for patients with complex aortic
aneurysmal disease, a signiﬁcant number will still require
custom-made device repair until additional device designs
become available. Early experience with OTS devices does
not demonstrate any signiﬁcant renal risks; however, the
treatment numbers are low and should be interpreted
with caution until larger conﬁrmatory studies are
published. Further studies comparing the outcomes of
these techniques are required to establish the best
approach to handle endovascular repair of complex aortic
aneurysm.The effect of surgeon specialization on outcomes after
ruptured abdominal aortic aneurysm repair
Alexander T., Hawkins, Ann D., Smith, Maria J., Schaumeier,
Marit S., de Vos, Nathanael D., Hevelone, Louis L., Nguyen
Objective: Although mortality after elective abdominal
aortic aneurysm (AAA) repair has steadily declined, oper-
ative mortality for a ruptured AAA (rAAA) remains high.
Repair of rAAA at hospitals with a higher elective aneurysm
workload has been associated with lower mortality rates
irrespective of the mode of treatment. This study sought to
determine the association between surgeon specialization
and outcomes after rAAA repair.
Methods: The American College of Surgeons National Surgical
Quality Improvement Project database from 2005 to 2010was
used to examine the 30-daymortality andmorbidity outcomes
of patients undergoing rAAA repair by vascular and general
surgeons. Multivariable logistic regression analysis was per-
formed for each death and morbidity, adjusting for all inde-
pendently predictive preoperative risk factors. Survival curves
were compared using the log-rank test.
Results: We identiﬁed 1893 repairs of rAAAs, of which 1767
(96.1%) were performed by vascular surgeons and 72 (3.9%)
were performed by general surgeons. There were no sig-
niﬁcant differences between patients operated on by gen-
eral vs vascular surgeons in preoperative risk factors or
method of repair. Overall 30-day mortality was 34.3% (649
of 1893). After risk adjustment, mortality was signiﬁcantly
lower in the vascular surgery group compared with the
general surgery group (odds ratio [OR], 0.51; 95% con-
ﬁdence interval [CI], 0.30-0.86; P = .011). The risk of
returning to the operating room (OR, 0.58; 95% CI, 0.35-
0.97; P = .038), renal failure (OR, 0.54; 95% CI, 0.31-0.95;
P = .034), and a cardiac complication (OR, 0.53; 95% CI,
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surgery group.
Conclusions: Despite similar preoperative risk factors
proﬁles, patients who were operated on by vascular sur-
geons had lower mortality, less frequent returns to the
operating room, and decreased incidences of post-
operative renal failure and cardiac events. These data add
weight to the case for further centralization of vascular
services.Routine use of completion imaging after infrainguinal
bypass is not associated with higher bypass graft patency
Tze-Woei, Tan, Denis, Rybin, Jeffrey A., Kalish, Gheorghe,
Doros, Naomi, Hamburg, Andres, Schanzer, Jack L.,
Cronenwett, Alik, Farber
Background: Signiﬁcant variability exists in completion
imaging (CIM) after infrainguinal lower extremity bypass
(LEB). We evaluated the use of CIM and compared graft
patency in patients treated by surgeons who performed
routine CIM vs those who performed selective CIM.
Methods: We reviewed the Vascular Study Group of New
England database (2003-2010) and assessed the use of CIM
(angiography or duplex ultrasound) among patients under-
going LEB. The surgeon-speciﬁc CIM strategy was catego-
rized as routine (80% of LEBs) vs selective (<80% of LEBs).
Exclusion criteria included acute limb ischemia, bilateral
procedures, and surgeon volume <10 cases per study
period. Primary graft patency at discharge and at 1 year was
analyzed on the basis of CIM use and surgeon-speciﬁc CIM
strategy. Multivariable analyses were performed using
Poisson regression.
Results: Among 2032 LEB procedures performed by 48 sur-
geons, CIM was used in 1368 cases (67.3%). CIM was per-
formed in 72% of autogenous LEBs and 52% of prosthetic
grafts. Dialysis (odds ratio [OR], 1.7; 95% conﬁdence interval
[CI], 1.1-2.6; P = .01), elective LEB (OR, 2.6; 95% CI, 1.4-4.8;
P = .002), great saphenous vein conduit (OR, 2.0; 95% CI, 1.6-
2.5; P < .001), and tibial or pedal target artery (OR, 1.8; 95%
CI, 1.4-2.3; P < .001) were associated with CIM use. In mul-
tivariate models, CIM was not associated with improved
primary graft patency at discharge (OR, 1.1; 95% CI, 0.7-1.7;
P = .64) or at 1 year (OR, 0.9; 95% CI, 0.7-1.2; P = .47). Sixteen
surgeons (33%) were routine users and 32 (67%) were
selective users of CIM. Among patients of routine vs selective
CIM users, primary graft patency at discharge and at 1 year
was 96% vs 94% (P = .21) and 68% vs 72% (P = .09), respec-
tively. In multivariate analysis, routine or selective CIM
strategy was not associated with improved discharge (rate
ratio, 0.8; 95% CI, 0.6-1.1; P = .31) or 1-year (rate ratio, 1.1;
95% CI, 0.9-1.2; P = .56) graft patency.
Conclusions: In our observational cohort, CIM does not
improve short-term and 1-year bypass graft patency in
infrainguinal LEB. The surgeon-speciﬁc strategy of selective
CIM after LEB has outcomes comparable to those of routine
CIM.Retrograde open mesenteric stenting for acute mesenteric
ischemia
Juliette T.M., Blauw, Robert, Meerwaldt, Marjolein,
Brusse-Keizer, Jeroen J., Kolkman, Dick, Gerrits, Robert
H., Geelkerken
Objective: Acute mesenteric ischemia (AMI) encompasses
the sequels of end-stage untreated chronic mesenteric
ischemia and acute mesenteric artery thrombosis. Percu-
taneous mesenteric artery stenting (PMAS) is the preferred
treatment of patients with AMI but is not always feasible.
Retrograde open mesenteric stenting (ROMS) is a hybrid
technique that combines the advantages of open surgical
and endovascular approaches. The literature on the results
of this new technique is scarce. The aim of this study was to
evaluate the results of ROMS in a consecutive series of
patients with AMI.
Methods: All patients with emergent mesenteric revascu-
larization for AMI between January 2007 and September
2011 were entered in our prospective registry. Technical
success, mortality, patency, clinical success, and complica-
tion rate at 30 days and 6 and 12 months were assessed.
Results: Sixty-eight patients presented with AMI and 54
underwent PMAS, of which four were unsuccessful and fol-
lowed by ROMS. Eleven patients were directly treated with
ROMS, making a total of 15 patients (10 women and ﬁve
men; median age, 66 years [interquartile range, 54-
73 years]). In all patients, only the superior mesenteric artery
was revascularized. In nine of the 15 patients, all three
mesenteric arteries were severely stenotic or occluded.
Technical success was achieved in 14 patients. At ROMS in
two patients, the small bowel was severely ischemic. One of
these patients needed a partial bowel resection because of
irreversible transmural ischemia. At 30 days, the mortality
rate was 20% and the primary patency was 92%.Ten patients
underwent unplanned relaparotomy, of whom one needed
resection of a large part of the small bowel. At 12months, the
mortality rate was still 20%. The primary patency was 83%.
Primary assisted patency was 91%, and secondary patency
was 100%. Clinical success at 30 days, 6 months, and
12 months, respectively, was 73%, 67%, and 67%.
Conclusions: AMI is still a devastating event. If PMAS is not
feasible, ROMS is a reliable alternative and is associated
with a relatively low mortality and morbidity rate.Prospective, randomized study of cutting balloon
angioplasty versus conventional balloon angioplasty for
the treatment of hemodialysis access stenoses
Hossam M., Saleh, Ahmed K., Gabr, Mohamed M., Tawﬁk,
Hesham, Abouellail
Objective: The aim of this trial was to compare the rates of
patency achieved by cutting and conventional balloon
angioplasty to treat hemodialysis access stenoses.
Methods: End-stage renal failure patients (at three tertiary
referral centers) with signiﬁcant hemodialysis access
stenoses were prospectively randomized to have
354 Abstractspercutaneous transluminal angioplasty (PTA) by either cut-
ting or conventional balloons. Patients with more than one
hemodynamically signiﬁcant stenosis were excluded.
Kaplan-Meier method was used to compare the primary
assisted patency rates for the two groups.
Results: The study randomized 623 patients into two
groups, and the duration of follow-up was 15  3 months.
In the cutting balloon angioplasty group, the clinical success
rate was 89% (282 of 316 stenoses). In the conventional
balloon angioplasty group, the clinical success rate was 86%
(265 of 307 stenoses; P = .637). Assisted primary patency for
cutting PTA was statistically signiﬁcantly higher at 6 months
and 1 year (86% and 63%) than that for conventional PTA
(56% and 37%, respectively; P = .037) in the treatment of
stenosis of the graft-to-vein anastomosis. In the venous
stenosis subgroup, equivalent primary assisted patency at
6 months and 1 year was observed for cutting PTA (84% and
55%) and conventional PTA (70% and 46%, respectively; P =
.360). In the intragraft stenosis subgroup, primary assisted
patency was equivalent at 6 months and 1 year for cutting
PTA (67% and 39%) and conventional PTA (62% and 49%,
respectively; P = .371). In the arterial anastomotic stenosis
subgroup, assisted primary patency at 6 months and 1 year
was equivalent for cutting PTA (70% and 30%) and con-
ventional PTA (75% and 33%, respectively; P = .921).
Conclusions: Cutting balloon angioplasty proved to be a
safe and effective treatment of graft-to-vein anastomotic
stenosis, with signiﬁcantly higher patency than that of
conventional balloon angioplasty.Radiation-induced skin injury after complex endovascular
procedures
Melissa L., Kirkwood, Gary M., Arbique, Jeffrey B., Guild,
Carlos, Timaran, R. James, Valentine, Jon A., Anderson
Background: Radiation-induced skin injury is a serious
potential complication of ﬂuoroscopically guided inter-
ventions. Transient erythema occurs at doses of 2 to 5 Gy,
whereas permanent epilation, ulceration, and desquamation
are expected at doses above this level. Complex endovas-
cular procedures (CEPs), such as fenestrated endovascular
aortic aneurysm repair (FEVAR), are associated with high
radiation doses, yet the prevalence of radiation-induced skininjury is unknown. We hypothesized that skin injury after
these exposures is likely to be underrecognized and under-
reported. This study examined the frequency and severity of
deterministic effects and evaluated patient characteristics
that might predispose to radiation injury in CEP.
Methods: CEP was deﬁned as a procedure with a radiation
dose 5 Gy (National Council on Radiation Protection and
Measurements threshold for substantial radiation dose level
[SRDL]). Radiation dose and operating factors were recor-
ded for all CEPs performed in a hybrid room during a 30-
month period. Patient medical records were retrospectively
reviewed for evidence of skin injury. Patients were seen in
follow-up daily until discharge and then at weeks 2 and 6,
months 3 and 6, and 1 year. Phone interviews were con-
ducted to determine the presence of any skin-related
complaints. Peak skin dose (PSD) distributions were calcu-
lated for FEVARs with custom software employing input
data from ﬂuoroscopic machine logs. These calculations
were validated against Gafchromic ﬁlm (Ashland Inc, Cov-
ington, Ky) measurements. Dose was summed for the
subset of patients with multiple procedures within
6 months of the SRDL event, consistent with Joint Com-
mission recommendations.
Results: Sixty-one CEPs reached a reference air kerma (RAK)
of 5 Gy (50 FEVARs, six embolizations, one thoracic endo-
vascular aortic repair, one endovascular aneurysm repair,
one carotid intervention, and two visceral interventions).
The patient cohort was 79% male and had a mean body
mass index of 31. The average RAK was 8  2 Gy (5.0-
15.9 Gy). Sixteen patients had multiple CEPs within
6 months of the SRDL event, with a mean cumulative RAK
of 12  3 Gy (7.0-18.4 Gy). The mean FEVAR PSD was 6.6 
3.6 Gy (3.7-17.8 Gy), with a mean PSD/RAK ratio of 0.78.
Gafchromic ﬁlm dose measurements were not statistically
different from PSD estimations, with a constant of pro-
portionality of 0.99. Three patients were lost to follow-up
before their ﬁrst postoperative visit. No radiation skin
injuries were found.
Conclusions: This study represents the largest analysis of
deterministic skin injury after CEPs, and our results suggest
that it is less frequent than expected and not increased in
CEPs.
